Junhe Alliance Biopharmaceutical

Junhe Alliance Biopharmaceutical is a clinical-stage Chinese biotechnology company specializing in the development of recombinant protein drugs and synthetic biology applications. The company focuses on high-barrier therapeutic areas including growth hormones, insulin analogs, and medical aesthetics, utilizing a proprietary high-efficiency protein expression and purification platform. Its lead programs include a recombinant human growth hormone (rhGH) and a recombinant botulinum toxin type A, both aimed at addressing significant unmet needs in the metabolic and aesthetic markets. Junhe Alliance operates integrated R&D and manufacturing facilities in Beijing and Shanghai to support its transition from a research-focused entity to a commercial-stage biopharmaceutical firm.